HLA Class I Allele Polymorphism in Moroccan Hepatitis C Patients
Author Information
Author(s): Machraoui Safa, Hakmaoui Abdelmalek, Errafii Khaoula, Knidiri Mehdi, Essaadouni Lamiaa, Krati Khadija, Admou Brahim, Huang Ru Chih C.
Primary Institution: Mohammed VI University Hospital, Marrakech, Morocco
Hypothesis
The study investigates the relationship between HLA-A and HLA-B allele polymorphism and its impacts on the clinical outcome of HCV.
Conclusion
The study found significant differences in HLA allele frequencies between HCV-infected patients and healthy controls, suggesting certain alleles may influence disease susceptibility and clearance.
Supporting Evidence
- HLA-A*02:01 was less prevalent in chronic HCV infection, indicating a potential protective effect.
- Higher prevalence of HLA-A*68:02 and other alleles in patients suggests a predisposition to chronic HCV infection.
- The study highlights the importance of HLA allele diversity in HCV infection outcomes.
Takeaway
This study looked at how different genes in people might affect their chances of getting better from hepatitis C. Some genes seem to help people fight the virus, while others might make it harder.
Methodology
A cross-sectional and comparative study was conducted on 40 HCV-infected patients and 100 healthy controls, using high-resolution PCR-SSO for HLA typing.
Potential Biases
Potential biases may arise from the selection of control subjects and the retrospective nature of data collection.
Limitations
The study's findings need validation in larger and more diverse populations.
Participant Demographics
55% of the patients were female, with a mean age of 55.4 years.
Statistical Information
P-Value
p = 0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website